Page last updated: 2024-08-16

mitomycin and sphingosine

mitomycin has been researched along with sphingosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albino, AP; Dhupar, SK; Ehleiter, D; Fuks, Z; Haimovitz-Friedman, A; Kelsen, DP; Lai, L; Loganzo, F; Maslak, P; Schwartz, GK1
Hama-Inaba, H; Matsushima, T; Mori, M; Muto, M; Ohyama, H; Saitoh, T; Takusagawa, M; Wang, B; Yamada, T1
Kepp, O; Kroemer, G; Martins, I; Métivier, D; Michaud, M; Perfettini, JL; Schlemmer, F; Senovilla, L; Séror, C; Tesniere, A; Zitvogel, L1
Beattie, AR; Levine, MA; Lukowski, ZL; Meyers, CA; Min, J; Samuelson, DA; Schultz, GS; Sherwood, MB; Stoller, G1
Hu, CY; Lan, KH; Lu, Q; Tang, W; Wang, SF; Yin, GJ1

Other Studies

5 other study(ies) available for mitomycin and sphingosine

ArticleYear
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
    Journal of the National Cancer Institute, 1995, Sep-20, Volume: 87, Issue:18

    Topics: Apoptosis; Drug Resistance; Drug Synergism; Humans; Mitomycin; Protein Kinase C; Sphingosine; Stereoisomerism; Stomach Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1995
Radio-sensitive murine thymoma cell line 3SB: characterization of its apoptosis-resistant variants induced by repeated X-irradiation.
    Mutation research, 1998, Jul-17, Volume: 403, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Daunorubicin; Drug Resistance; Genetic Variation; Methyl Methanesulfonate; Mice; Mitomycin; Mutagens; Radiation Tolerance; Sphingosine; Thymoma; Thymus Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1998
Chemotherapy induces ATP release from tumor cells.
    Cell cycle (Georgetown, Tex.), 2009, Nov-15, Volume: 8, Issue:22

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cadmium; Cell Line, Tumor; Cisplatin; Etoposide; Flow Cytometry; Fluorescent Antibody Technique; Mice; Mitomycin; Mitoxantrone; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Sphingosine; Thapsigargin

2009
Prevention of ocular scarring after glaucoma filtering surgery using the monoclonal antibody LT1009 (Sonepcizumab) in a rabbit model.
    Journal of glaucoma, 2013, Volume: 22, Issue:2

    Topics: Alkylating Agents; Animals; Antibodies, Monoclonal, Humanized; Cicatrix; Conjunctiva; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fibrosis; Filtering Surgery; Glaucoma; Injections; Lysophospholipids; Mitomycin; Postoperative Complications; Rabbits; Sphingosine; Surgically-Created Structures; Wound Healing

2013
[Antitumor effect of sphingosine kinase 1 inhibitor in combination with chemotherapy on SGC7901 gastric cancer cells in vitro].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:2

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Enzyme Inhibitors; Fluorouracil; Humans; Mitomycin; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Stomach Neoplasms

2012